Free Trial

Exelon Co. (NASDAQ:EXC) Shares Acquired by Charles Schwab Investment Management Inc.

Exelon logo with Utilities background

Charles Schwab Investment Management Inc. increased its stake in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 4.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,729,004 shares of the company's stock after purchasing an additional 282,596 shares during the period. Charles Schwab Investment Management Inc. owned 0.67% of Exelon worth $253,280,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp increased its stake in Exelon by 3.7% during the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company's stock worth $2,439,862,000 after buying an additional 2,156,259 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Exelon by 1.6% during the third quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company's stock worth $1,048,823,000 after purchasing an additional 403,542 shares in the last quarter. FMR LLC increased its position in shares of Exelon by 18.7% during the third quarter. FMR LLC now owns 11,782,549 shares of the company's stock worth $477,782,000 after purchasing an additional 1,858,502 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Exelon by 1.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company's stock valued at $363,626,000 after purchasing an additional 160,313 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Exelon by 109.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company's stock valued at $238,608,000 after purchasing an additional 3,068,309 shares in the last quarter. 80.92% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Exelon

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the company's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total transaction of $59,353.91. Following the transaction, the executive vice president now directly owns 2,271 shares in the company, valued at $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.10% of the company's stock.

Wall Street Analyst Weigh In

EXC has been the subject of a number of recent research reports. Guggenheim upgraded shares of Exelon from a "neutral" rating to a "buy" rating in a research report on Thursday, January 23rd. Evercore ISI upgraded shares of Exelon from an "in-line" rating to an "outperform" rating and increased their price objective for the company from $43.00 to $44.00 in a report on Tuesday, January 21st. Scotiabank raised their target price on shares of Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research note on Thursday, February 13th. BMO Capital Markets restated an "outperform" rating on shares of Exelon in a research report on Tuesday, February 4th. Finally, Morgan Stanley cut their price target on Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a report on Friday, November 22nd. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $44.13.

Read Our Latest Research Report on EXC

Exelon Stock Down 0.7 %

Shares of NASDAQ EXC opened at $43.36 on Thursday. The company has a market capitalization of $43.59 billion, a P/E ratio of 17.70, a P/E/G ratio of 2.86 and a beta of 0.51. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.87 and a quick ratio of 0.78. The company has a 50 day simple moving average of $40.52 and a 200-day simple moving average of $39.47. Exelon Co. has a 1 year low of $34.01 and a 1 year high of $45.19.

Exelon (NASDAQ:EXC - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same quarter in the previous year, the business earned $0.60 earnings per share. On average, equities research analysts predict that Exelon Co. will post 2.64 earnings per share for the current year.

Exelon Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.69%. The ex-dividend date is Monday, February 24th. This is a positive change from Exelon's previous quarterly dividend of $0.38. Exelon's dividend payout ratio (DPR) is 65.31%.

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC - Free Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla Sinks on Musk Drama—Bounce or Bigger Crash?
3 AI Stocks to Watch After NVIDIA’s Dip
Congress Cashes In on Stocks—Here’s How You Can Too!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines